The Food and Drug Administration shocked lawmakers, advocates and the pharmaceutical industry when it asked a drugmaker to pull an opioid from store shelves.

The agency’s decision Thursday evening to ask Endo Pharmaceuticals to remove the painkiller Opana Extended Release from the market — the first such request by the FDA — came after years of lawmakers saying that the FDA approved too many opioids and contributed to a growing epidemic.